BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9068981)

  • 1. Central serotonin level-dependent changes in body temperature following administration of tryptophan to pargyline- and harmaline-pretreated rats.
    Abdel-Fattah AF; Matsumoto K; Murakami Y; Adel-Khalek Gammaz H; Mohamed MF; Watanabe H
    Gen Pharmacol; 1997 Mar; 28(3):405-9. PubMed ID: 9068981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitatory and inhibitory effects of harmaline on the tryptophan-induced 5-hydroxytryptamine syndrome and body temperature changes in pargyline-pretreated rats.
    Abdel-Fattah AF; Matsumoto K; Murakami Y; El-Hady KA; Mohamed MF; Watanabe H
    Jpn J Pharmacol; 1996 Sep; 72(1):39-47. PubMed ID: 8902598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT1A and 5-HT2 receptors mediate hypo- and hyperthermic effects of tryptophan in pargyline-pretreated rats.
    Abdel-Fattah AF; Matsumoto K; el-Hady KA; Watanabe H
    Pharmacol Biochem Behav; 1995 Oct; 52(2):379-84. PubMed ID: 8577805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats.
    Boban Blagaic A; Blagaic V; Mirt M; Jelovac N; Dodig G; Rucman R; Petek M; Turkovic B; Anic T; Dubovecak M; Staresinic M; Seiwerth S; Sikiric P
    Eur J Pharmacol; 2005 Apr; 512(2-3):173-9. PubMed ID: 15840402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of various drugs on serum free and total tryptophan levels and brain tryptophan metabolism in rats.
    Iwata H; Okamoto H; Ko S
    Jpn J Pharmacol; 1975 Jun; 25(3):303-10. PubMed ID: 127058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothermic effect of harmala alkaloid in rats: involvement of serotonergic mechanism.
    Abdel-Fattah AF; Matsumoto K; Gammaz HA; Watanabe H
    Pharmacol Biochem Behav; 1995 Oct; 52(2):421-6. PubMed ID: 8577810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in behavioral and thermal responses to pargyline and tryptophan.
    Biegon A; Segal M; Samuel D
    Psychopharmacology (Berl); 1979 Mar; 61(1):77-80. PubMed ID: 108723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial interstitial serotonin and its major metabolite, 5-hydroxyindole acetic acid levels determined by microdialysis technique in rat heart.
    Du CK; Zhan DY; Akiyama T; Sonobe T; Inagaki T; Shirai M
    Life Sci; 2014 Nov; 117(1):33-9. PubMed ID: 25277944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of local MAO inhibition in the locus coeruleus on extracellular serotonin and 5-HIAA during exposure to sensory and cardiovascular stimuli.
    Kaehler ST; Philippu A; Singewald N
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):187-93. PubMed ID: 10208305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin synthesis and release in brain slices: independence of tryptophan.
    Elks ML; Youngblood WW; Kizer JS
    Brain Res; 1979 Aug; 172(3):471-86. PubMed ID: 113050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute cocaine treatment on the turnover of 5-hydroxytryptamine in the rat brain.
    Friedman E; Gershon S; Rotrosen J
    Br J Pharmacol; 1975 May; 54(1):61-4. PubMed ID: 1139076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the anticonvulsant valproic acid on cerebral indole amine metabolism.
    MacMillan V
    Can J Physiol Pharmacol; 1979 Aug; 57(8):843-7. PubMed ID: 387187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain serotonin turnover in chronically uremic rats.
    Siassi F; Wang M; Kopple JD; Swendseid ME
    Am J Physiol; 1977 May; 232(5):E526-8. PubMed ID: 871160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-hydroxy-3-ethylamino-2-oxindole is not formed in rat brain following a neurotoxic dose of methamphetamine: evidence that methamphetamine does not induce the hydroxyl radical-mediated oxidation of serotonin.
    Yang Z; Wrona MZ; Dryhurst G
    J Neurochem; 1997 May; 68(5):1929-41. PubMed ID: 9109519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of 6-fluoro-DL-tryptophan and its specific effects on the rat brain serotoninergic pathway.
    Chanut E; Trouvin JH; Bondoux D; Gardier A; Launay JM; Jacquot C
    Biochem Pharmacol; 1993 Mar; 45(5):1049-57. PubMed ID: 7681671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated rats.
    Fuller RW; Hemrick SK
    Life Sci; 1978 Mar; 22(12):1083-6. PubMed ID: 642716
    [No Abstract]   [Full Text] [Related]  

  • 17. Turnover of dopamine and serotonin and their metabolites in the striatum of aged rats.
    Venero JL; Machado A; Cano J
    J Neurochem; 1991 Jun; 56(6):1940-8. PubMed ID: 1709201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in serotonergic measures in whole blood and various brain regions of rats administered with the 5-HT1A agonist tandospirone and/or exposed to electric foot-shock.
    Takada Y; Urano T; Malyszko J; Takada A
    Brain Res Bull; 1996; 40(1):51-5. PubMed ID: 8722753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.